Specifically, peritoneal macrophages from mice treated with anti-CD40 antibody and CpG were able to inhibit tumour cell proliferation in vitro and suggested a potential role in vivo in an antigen-dependent manner. This evidence concerns the gene CD40 and neoplasm.